Part 1 | The EU AI Act and life sciences with Arne Thiermann

preview_player
Показать описание
Join Hamburg partner Arne Thiermann as he examines the EU AI Act from a life sciences sector perspective.

In part one of Arne's series, he explains how the EU AI Act places guardrails around AI innovation in pharma, med tech, and digital health and harmonizes with other regulations – such as the Medical Device Regulation.

Рекомендации по теме
welcome to shbcf.ru